medigraphic.com
Boletín Clínico de la Asociación Médica del Hospital Infantil del Estado de Sonora

2010, Number 1

<< Back Next >>

Bol Clin Hosp Infant Edo Son 2010; 27 (1)

Vacuna de Papilomavirus y Cáncer Cervicouteríno

Reyes-Gómez U, Reyes-Hernández U, Reyes-Hernández D, López-Cruz G, Javier-Hernández L, Quero-Hernández A

Language: Spanish
References: 12
Page: 52-55
PDF size: 49.93 Kb.


ABSTRACT

In developing countries like ours, the impact of Cervico-uterine cancer is a serious health problem in women. They represent about 80% of the 250,000 cancer deaths.
Vaccination as primary prevention strategy for a venereal disease results from human papillomavirus (HPV), long-term prevents the occurrence of cervical cancer. It is one of the most important advances in recent years and the beginning of a hope to bring down this high mortality and the possibility likewise under the same scheme for the development of other vaccines against other viruses.
The ideal target population for immunization programs against HPV will be girls and maybe boys before the start of their first sexual intercourse (from 10 years old), who is the best strategy for the future.


REFERENCES

  1. Bosch FX, Lorincz A, Muñoz N, Meijer C, Shah KV. The causal relation between human papillomavirus and cervical cancer. J. Clin Pathol. 2002; 55 (4): 244-65.

  2. Castellsague X Bosh FX, Muñoz N. The male role in cervical cancer. Salud Pública Mex 2003;suppl 3: s345-s353.

  3. Castellsague X, Bosch FX, Muñoz N, Meijer CJ, Shah KV, de Sanjosé S et al. male circumcision penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med. 202; 346(15): 1105-12.

  4. Bleeker MC, Hogewoning CJ, Voorhorst FJ, Van den Brule AJ, Snijders PJ, Starink TM et al condom use promotes regression of human papillomavirus- associates penile lesions in male sesual partners of women with cervical intraepithelial neoplasia, Int J Cancer. 2003; 107 (5): 804-10.

  5. Hogewoning CJ, Bleeker MC. Vanden Brule AJ, Voorhorst FJA, Snijders PJ, Berkhof J et al. condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. Int J Cancer 2003, 107(5): 811-6.

  6. Castellsague X Muñoz N. chapter 3: cofactors in human papillomavirus carcinogenesis – role or parity, oral contraceptives, and tobacco smoking. J Nal Cancer Inst Monogr. 2003 ; (31): 20-8.

  7. Castellsague X, Bosch FX, Muñoz N. environmental co- factors in hpv carcinogenesis. Virus Res.2002; 89(2): 191-9.

  8. Garcia CR, Castellague X, Bosch X, González CA. the role of diet and nutrition in cervical carcinogenesis: a review of recent evidence. Int J Cancer 2005; 117 (4): 629-37.

  9. SmithJS, Bosetti AC, Muñoz N, Herrero R, Bosch FX, Eluf Neto J et al Chlamdia trachomatis and invasive cervical cancer: a pooled analysis of the iarc multicentric case- control study. Int J Cancer. 2004; 111(3): 431-9.

  10. Smith JS, Herrero R, Bosetti C, Muñoz N. Bosch FX, Eluf-Neto J et al. herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. National Cancer Instit.2002; 94 (21): 1604-13.

  11. Adis Drug Profile. Vacuna Recombinante Tetravalente (tipos 6, 11, 16,18) Contra el Virus del Papiloma Humano (gardasil). Drugs 2006; 66(9): 1263-71.

  12. Sam SS, Gayón VE. Guía práctica para el abordaje y manejo de lesiones anogenitales por virus de papiloma humano en adolescentes Acta Ped. Mex 2006; 27(3): 151-6.




2020     |     www.medigraphic.com